PW01-023 – Ex vivo PBMC cytokine profile in FMF patients by unknown
MEETING ABSTRACT Open Access
PW01-023 – Ex vivo PBMC cytokine profile in FMF
patients
JN Ibrahim1,2*, R Jounblat2, A Delwail1, J Abou-Ghoch3, N Salem3, E Chouery3, A Megarbane3, J-C Lecron1,
M Medlej-Hashim2
From 7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Lausanne, Switerland. 22-26 May 2013
Introduction
Familial Mediterranean fever (FMF) is an autosomal
recessive autoinflammatory disorder affecting mainly
Jews, Armenians, Turks and Arabs. Recently, several
pro- and anti-inflammatory cytokines have been studied
in sera of Armenian and Turkish FMF patients during
and in between crises. However, the information were
limited and contradictory.
Objectives
This work aimed to evaluate the ex vivo and serum
cytokine profile of Lebanese FMF patients during acute
attacks and attack-free periods and to compare it with
that of healthy controls in order to identify a specific
cytokine ¨signature¨ and to understand the role of the
inflammasome in this autoinflammatory disease.
Methods
The study included 34 FMF patients, of whom 9 were
studied during both attack and remission and 25 healthy
controls. Cytokine levels were evaluated in serum and
supernatants of peripheral PBMC cultures with and
without 24h stimulation of monocytes by LPS and T
lymphocytes by anti-CD3/CD28 beads, by Luminex
Multiplex ELISA.
Results
Ex vivo cytokine profile
The levels of pro-inflammatory cytokines IL-6 and TNF-a
were higher in unstimulated and LPS stimulated PBMC
supernatants of FMF patients in crises compared to the
control group. Concentrations were comparable between
FMF patients during and between crises.
There was no difference in spontaneous IL1-b and IL-1
a release by PBMCs of FMF patients and controls. How-
ever, in response to LPS stimulation, levels of these cyto-
kines were found higher in PBMC supernatants of FMF
patients during crises compared to those in remission
and to the controls. In contrast, no difference was found
in IL1-RA levels between FMF patients and controls in
all conditions.
Regarding Th1 and Th2 cytokines, IFN-g and IL-4
levels were lower in unstimulated and anti-CD3/CD28
stimulated PBMCs supernatants of FMF patients during
and between crises compared to the controls. Moreover,
lower levels of those cytokines were detected in culture
supernatants of FMF patients during crises compared to
those in remission after T cell stimulation.
For Th17 cytokines, IL-17 was higher in anti-CD3/
CD28 stimulated PBMC supernatants of FMF patients
during crises compared to the control group. After T
cell stimulation, PBMCs from FMF patients in remission
release more IL-22 than PBMCs from control subjects.
Finally, no difference in IL-10 levels was detected
between FMF patients and controls.
Serum cytokine profile
Except IL-6, all cytokines tested, were almost not
detected in the serum of patients and controls.
Conclusion
The cytokine changes observed in FMF patients and
characterized by a continuous pro-inflammatory Th17
and IL-1 family cytokine activation and a reduced Th1
and Th2 response, suggest an ongoing subclinical
inflammation and represent a specific cytokine ¨signature¨
to FMF patients. In addition, these results do not show a
particular involvement of the inflammasome in FMF phy-
siopathology. Finally, we suggest that ex vivo study
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